NATIONAL & INTERNATIONAL

  • Wintrob Z.A.P., Hammel J.P., Khoury T., Nimako G.K., Fu H-W, Fayazi Z.S., Gaile D.P., Forrest A., Ceacareanu A.C. (2016) “Pharmacotherapy, cytokine profiles, and prognosis in women with diabetes mellitus and breast cancer”. International Immunology Congress, Bucharest, Romania
  • Yin K.Q., Nimako G.K., Wintrob Z.A.P., Ceacareanu A.C. (2016) “The pharmacology, clinical efficacy and safety of vitamin D supplementation in cancer patients”. American Society of Health-system Pharmacists Annual Meeting, Las Vegas, Nevada
  • Frohnapple C.B., Sulik D.A., Wintrob Z.A.P., Ceacareanu A.C. (2014) “Challenges and rewards of pharmacotherapy selection in patients newly diagnosed with lung cancer and diabetes mellitus”. American Society of Health-system Pharmacists Annual Meeting, Las Vegas, Nevada
  • Sulik D.A., Frohnapple C.B., Wintrob Z.A.P., Ceacareanu A.C. (2014). “Pharmacotherapy and beyond: who has the gut to make it through colorectal cancer?”. American Society of Health-system Pharmacists Annual Meeting, Las Vegas, Nevada
  • Wintrob Z.A.P., Fung M.C., Bear M.D., Fyles A.W., Bui T.Q., Brown G.W., Ceacareanu A.C. (2014) “Could pharmacy students identify risk for lactic acidosis after contrast dye administration in leukemia patients treated with metformin?”. European Association of Faculties of Pharmacy, Ljubljana, Slovenia
  • Wintrob Z.A.P., Radpasand H., Elmeshad M., Barima A., Rabey J.L., Chmiel K., Fayazi Z., Otvos L., Surmacz E., Faitar S.L., Ceacareanu A.C. (2013) “Adiponectin receptor-mediated weight regulation: an inflammation-independent mechanism?”. Experimental Biology Meeting, Boston, Massachusetts
  • Wintrob Z.A.P., Oppong E.K., Tse Y.C., Boateng H.R., Welt J.M., Martorana M., Drumea I.M. Irlam I., LeVea C.M., Faitar S.L., Ceacareanu A.C. (2013) “Inflammation and sexual dimorphism in development of insulin resistance: a dual animal model comparison”. Experimental Biology Meeting, Boston, Massachusetts
  • Salsabili M., Bear M.D., Abd-Elrahman A.A., Markus A.K., Schepart A.L., Yin J., Mashtare T., Sweet B., Ceacareanu A.C. (2013) “PharmD Student awareness of managed care pharmacy: a single site survey of professional preparedness”. American Society of Health-system Pharmacists Annual Meeting, Orlando, Florida
  • Fung M.C., Wintrob Z.A.P., Brown G.W., Wetzler M., Ceacareanu A.C. (2013) “Modeling of lactic acidosis risk post contrast dye in leukemia patients treated with metformin”. American Society of Health-system Pharmacists Annual Meeting, Orlando, Florida
  • Wintrob Z.A.P., Chuang H-C, Miller D.S., Rabey J.L., Bui T.Q., Amsler M.E., Salsabili M., Ford L.A., Wetzler M., Ceacareanu A.C. (2013) “Missing the benefit of metformin in acute myeloid leukemia: a problem of contrast”. American Association for Cancer Research Annual Meeting, Washington DC. Cancer Res April 15, 2013 73; LB-
  • Amsler M.E., Chmiel K.A., Yaremko O., Carroll C., Yin J., Mashtare T., Miliotto A., Brightwell R., Odunsi K., Ceacareanu A.C.. (2013) “Statins use prevents ovarian cancer recurrence in women with diabetes mellitus”. American Association for Cancer Research Annual Meeting, Washington DC. Cancer Res April 15, 2013 73; LB-18
  • Ceacareanu A.C., Hong C-C., Shah A.B., Jackowiak C.M., Fu H-W., Nimako G.K., Kossoff E., Wintrob Z.A.P., Forrest A. (2012) “Use of insulin sensitizers is associated with better hormone-receptor pattern and improved survival in breast cancer”. American Association for Cancer Research Annual Meeting, Chicago, Illinois. Cancer Res. 72(8), S1
  • Kossoff E., Batty N., Ceacareanu A.C., Attwood K., Miller D.S., Rabey J.L., Lee C., Ahmad A., Ebos J.M., Schwaab T., Saby G., Pili R. (2012) “Evaluation of parameters for treatment duration of sunitinib in metastatic renal cell carcinoma”. American Society of Clinical Oncologists Annual Meeting. J Clin Oncol 30, 2012 (suppl; abstr e15042)
  • Miller D.S., Wintrob Z.A.P., Ceacareanu A.C. (2012) “Lipid Management and Prostate Cancer Outcomes in Patients with Type 2 Diabetes Mellitus” American Society of Health-system Pharmacists Annual Meeting, Las Vegas, Nevada
  • Bui T.Q., Chmiel K., Wintrob Z.A.P., Rodman H., Li A., Ford L.A., Wetzler M., Ceacareanu A.C. (2012)“Effect of pre-existing statin therapy on acute myeloid leukemia prognosis”. American Society of Health-system Pharmacists Annual Meeting, Las Vegas, Nevada
  • Ceacareanu A.C., Hong C-C., Nimako G.K., Patel K., Kossoff E., Forrest A. (2011) “Statin treatment use in diabetic patients with breast cancer: A potential C-reactive protein-mediated benefit”. J Clin Oncol. Sep 20;29(27):173
  • Hong C-C., Ambrosone C., Ceacareanu A.C., Wintrob Z.A.P., Kokolus K., Davis W., Bovbierg D.H., Jenkins F.J., Edge S.B., Kulkarni S., O’Connor T. (2011)“Changes in circulating hormone levels and weight among women with early-stage breast cancer”. American Journal of Epidemiology 173:S257
  • Zou J., Jafr G., Themistou E., Yap Y., Alexandridis P, Ceacareanu A.C., Cheng C. (2010) “Synthesis, characterization, and biomedical assessment of pH-sensitive brush polymer-drug conjugates”. Polymer Preprints. 51(2), 323
  • Fu H-W., Wintrob Z.A.P., Martens C.J., Kossoff E., Ceacareanu A.C. (2010) “Could cholesterol drugs modulate inflammation in type 2 diabetics with breast cancer?”. American Society of Health-system Pharmacists Annual Meeting, Anaheim, California
  • Shah A.B., Jackowiak C.M., Ekonomidis D., Hong C-C., Ceacareanu A.C. (2010) “Cholesterol drugs improve disease-free survival in type 2 diabetics with breast cancer”. American Society of Health-system Pharmacists Annual Meeting, Anaheim, California
  • Ceacareanu A.C., Hong C-C., Elgebaly M., Epstein M., Wintrob Z.A.P., Kossoff E., Yeow D., Boateng H., Welt J.M., Fu H-W., Wightman S., Forrest A. (2010) “Diabetes pharmacotherapy: A potential modifier of breast cancer prognosis”. 101st Annual Meeting of the American Association for Cancer Research, Washington DC
  • Ceacareanu A.C., Ford M., Coleman I., Cannon M. (2006) “Analysis of inappropriate use of oral chemotherapy in a Southern health plan”. Academy of Managed Care Pharmacy Educational Conference, Chicago, Illinois
  • Ceacareanu A.C., Chang Y., Ceacareanu B., Zhuang D., Hassid A. (2005)“Rac1 induces up-regulation of PTP-mRNA levels in cultured RASMC”. Poster session –XIII th FASEB Meeting, San Diego, California
  • Ceacareanu A.C., Ceacareanu B., Zhuang D., Chang Y., Ray R.M., Desai L., Chapman K.E., Waters C.M., Hassid A. (2004) “Nitric oxide attenuates IGF-1-induced RASM cell motility by decreasing Rac1 activity: essential role of PTP-PEST and p130cas”. American Heart Association Meeting, New Orleans, Louisiana. Circulation 110(17)
  • Ceacareanu A.C., Hillebrand A., Alexandrov K. (1998) “Chemo-enzymatic synthesis of the fluorescent complex Rab7: GDP Dissociation Inhibitor”. Federation of the European Biochemistry Societies Meeting, Spetses, Greece

LOCAL & REGIONAL

  • Yin K.Q., Wintrob Z.A.P., Lin L-H., Nimako G.K., Kapoor S., Abdelrahman N., Ceacareanu A.C. (2016) “Impact of statin and beta-blocker type on head and neck cancer outcomes”. New York State Chapter ACCP Annual Clinical Meeting, Rochester, New York
  • Abdelrahman N., Wintrob Z.A.P., Kapoor S., Yin K.Q., Lin L-H., Nimako G.K., Ceacareanu A.C. (2016) “Metformin attenuates the detrimental effects of insulin in head and neck cancers”. Collegiate Science and Technology Entry Program Symposium. Buffalo, New York – 1ST PRIZE POSTER WINNER
  • Brown G.W., Moussa H., Wintrob Z.A.P., Bear M.D., Fyles A.W., Alin A., Ford L., Ceacareanu A.C. (2016) “Metformin and renal function after administration of contrast media in patients with AML: a pharmacokinetic assessment”. 55th NYSCHP Annual Assembly Poster Session at the Saratoga Hilton, Saratoga Springs, New York
  • Brown G.W., Moussa H., Wintrob Z.A.P., Bear M., Fyles A., Ford L.A., Ceacareanu A.C. (2016) “Metformin and renal function after administration of contrast dye in patients with acute myeloid leukemia: a pharmacokinetic assessment”. Annual SUNY Undergraduate Research Conference. Cobleskill, NY. April 2016
  • Donato J.L., Nimako G.K., Wintrob Z.A.P., Sulik D.A., Ceacareanu A.C. (2015) “Evaluating the impact of GERD-associated comorbidities on gastrointestinal cancers outcomes”. Collegiate Science and Technology Entry Program Symposium. Buffalo, New York – 1ST PRIZE POSTER WINNER
  • McKenzie A., Wintrob Z.A.P., Elmeshad M., Rabey J., Chmiel K.A., Radpasand H., Barima A., Fayazi Z.S., Ceacareanu A.C. (2014) “Effect of estrogen on the development of fatty liver in high fat fed SCID mice”. Collegiate Science and Technology Entry Program Symposium. Buffalo, New York
  • Epstein M., Barima A., Brennan J., Nimako G.K., Patel K., Hong C-C., Kossoff E., Ceacareanu A.C. (2012) “Assessing the prognostic value of insulin resistance biomarkers in diabetics with breast cancer”. Collegiate Science and Technology Entry Program Symposium. Buffalo, New York
  • Harrington C., Brody P.M., Riebandt G., Wetzler M., Ceacareanu A.C. (2011) “Oncology workforce shortage: unaccounted need for cancer-educated pharmacists”. University at Buffalo, SoPPS Annual Student Research Symposium
  • Rickert M., Drumea I.M., Epstein M., Boateng H., Ceacareanu A.C. (2009) “Impact of repetitive freezing, hemolysis and dilution on cytokine and growth factor profiling by Luminex®”. Collegiate Science & Technology Entry Program Symposium, University at Buffalo, New York
  • Ceacareanu A.C., Evans A.G., Link A.B., Morgan C.R., Claiborne P.A. (2008) “Appropriateness of Antiemetic Premedication in Oncology Patients Receiving Chemotherapy”. Southeastern Residency Conference, Athens, Georgia
Advertisements